Heterotopic Ossification: Pharmacologic Options

被引：20

作者：

Cullen, Nora ^{[1
,2
]}

Perera, Jerome ^{[3
]}

机构：

[1] Univ Toronto, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada

[2] Univ Toronto, Div Physiatry, Toronto, ON M5G 2A2, Canada

[3] Univ Toronto, Fac Med, Toronto, ON M5G 2A2, Canada

来源：

JOURNAL OF HEAD TRAUMA REHABILITATION | 2009年 / 24卷 / 01期

关键词：

BRAIN-INJURY; HIP;

D O I：

10.1097/HTR.0b013e31819a8fcc

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：69 / 71

页数：3

共 15 条

[1] Prevention of heterotopic ossification after spinal cord injury with indomethacin
Banovac, K
Williams, JM
Patrick, LD
Haniff, YM
[J]. SPINAL CORD, 2001, 39 (07) : 370 - 374
[2] BUSCHBACHER R, 1992, CRIT REV PHYS MED RE, V4, P199
[3] C-reaction protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury
Estrores, IM
Harrington, A
Banovac, K
[J]. JOURNAL OF SPINAL CORD MEDICINE, 2004, 27 (05) : 434 - 437
[4] HARAN M, 2008, COCHRANE DB SYST REV, P4
[5] Brain injury severity and autonomic dysregulation accurately predict heterotopic ossification in patients with traumatic brain injury
Hendricks, Henk T.
Geurts, A. C. H.
van Ginneken, Bart C.
Heeren, Anita J.
Vos, Pieter E.
[J]. CLINICAL REHABILITATION, 2007, 21 (06) : 545 - 553
[6] HU HP, 1991, CLIN ORTHOP RELAT R, P259
[7] Pharmacological treatment of heterotopic ossification following hip and acetabular surgery
Macfarlane, Robert J.
Ng, Boon Han
Gamie, Zakareya
El Masry, Mohamed A.
Velonis, Stylianos
Schizas, Constantin
Tsiridis, Eleftherios
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (05) : 767 - 786
[8] Mahay PR, 1988, CLIN ORTHOP RELAT R, V237, P236
[9] Symptomatic heterotopic ossification after very severe traumatic brain injury in 114 patients: Incidence and risk factors
Simonsen, Louise Lau
Sonne-Holm, Stig
Krasheninnikoff, Michael
Engberg, Aase W.
[J]. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2007, 38 (10): : 1146 - 1150
[10] SPIELMAN G, 1983, ARCH PHYS MED REHAB, V64, P539

← 1 2 →